Brookstone Capital Management’s Filana Therapeutics FLNA Stock Holding History

Brookstone Capital Management’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-16,753	Closed	-$48.8K	–	1225
2025 Q3	$48.8K	Sell	16,753 -1,000	-6%	-$2.3K	﹤0.01%	1126
2025 Q2	$32.1K	Hold	17,753	–	–	﹤0.01%	1055
2025 Q1	$26.6K	Hold	17,753	–	–	﹤0.01%	1005
2024 Q4	$41.9K	Hold	17,753	–	–	﹤0.01%	981
2024 Q3	$522K	Hold	17,753	–	–	0.01%	677
2024 Q2	$170K	Buy	17,753 +1,000	+6%	+$21.1K	﹤0.01%	920
2024 Q1	$340K	Hold	16,753	–	–	0.01%	722
2023 Q4	$377K	Hold	16,753	–	–	0.01%	655
2023 Q3	$239K	Hold	16,753	–	–	0.01%	731
2023 Q2	$371K	Buy	+16,753	New	+$403K	0.01%	644

Other funds holding FLNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Brookstone Capital Management's FLNA Position: Q4 2025 in Review

Brookstone Capital Management sold out of Filana Therapeutics (FLNA) in Q4 2025, closing a stake of 16,753 shares — an estimated $48.8K sold.

Brookstone Capital Management first reported a position in FLNA in Q2 2023 and held it in 10 quarters. The position peaked at $522K in Q3 2024. 107 funds tracked by Wall St. Rank hold FLNA as of Q4 2025.

Brookstone Capital Management reported no remaining Filana Therapeutics position as of Q4 2025 after selling out during the quarter.
Brookstone Capital Management sold 16,753 Filana Therapeutics shares in Q4 2025, an estimated $48.8K.
Brookstone Capital Management first reported a position in Filana Therapeutics in Q2 2023 and held it in 10 quarters.
Brookstone Capital Management's Filana Therapeutics position peaked at $522K in Q3 2024.
107 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2025.

Based on Brookstone Capital Management's 13F filing for Q4 2025, filed 15 Jan 2026.